Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

Launched by MEIR HOSPITAL, KFAR SABA, ISRAEL · Oct 14, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how we can safely perform surgery for patients with femoral neck fractures who are taking a type of blood thinner called NOAC (New Oral Anticoagulants). Traditionally, doctors have waited at least 24 hours after a patient has taken these medications before proceeding with surgery, but this study aims to see if surgeries can be done sooner with minimal risk of bleeding. Researchers will monitor the amount of bleeding during surgery and check the levels of the NOAC medication in the blood to ensure safety.

To join this study, participants must be 18 years or older and have a femoral neck fracture while being able to provide informed consent. Some people may not be eligible, such as those under 18, those on certain blood-thinning medications like aspirin, or individuals with specific health conditions. If you participate, you can expect to undergo routine evaluations and monitoring during and after your surgery to help researchers understand the safety of earlier surgical intervention for patients on NOAC therapy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery
• • -
• Exclusion Criteria:
• • under 18 y.o
• • anti platelet therapy (aspirin is not included)
• • creatinine clearance under 50
• • active anti cancer therapy
• • ITP patients
• • non capable of making inform consent
• • patients which decide not to proceed with the expeirment